IndraLab

Statements

Olmesartan inhibits MAP3K7. 2 / 2
| 2
reach
"We may partially demonstrate the beneficial role of Olmesartan on patients with late-stage heart failure although we did not compare the role of Olmesartan and that of other sartans in the overload-pr[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
26706286
reach
"Taken together, our data suggested Olmesartan reduced phosphor-TAK1 and p38, which is involved in cardiac apoptosis and remodeling in the setting of stress."
26706286